Supporting the Physiatrist, Strengthening the Specialty

AAPM&R is working to ensure PM&R is positioned to thrive in the future of healthcare and that you’re prepared for wherever your career takes you. Our more than 10,000 Academy members support each other in advancing PM&R’s impact through healthcare. As we move forward, it is more important than ever that every member play an active role in helping one another realize the vision for our specialty.

Newsroom

Looking for AAPM&R members in the news? Press releases? Our Academy Action Center? Or looking to submit your members in the news content? You'll find it all in our Newsroom. You will also be able to explore PM&R and Academy news as well as learn how to contact us if you would like to submit your member content, or if you are a reporter who is interested in speaking with a PM&R physician.

Event Calendar and Webinars

Stay up to date on all Academy events and learning opportunities and view recordings of past webinars. 

PM&R Aspire

PM&R Aspire is our career-exploration platform purpose-built to help PM&R professionals make better-informed career decisions. We have mapped employer locations across the United States, enabling you to explore, message and apply to the roles that matter most to you.

PM&R Q&A Video Conversations

AAPM&R is leading the advancement of physiatry’s impact throughout healthcare as aligned with YOUR vision for the specialty. Explore our Q&A video series where members of our Physiatrist in Training (PHiT) Council Board chat with AAPM&R Board leaders.

Latest News

DEA and HHS Releases Second Temporary Extension for COVID-19 Telehealth Flexibilities

Oct 18, 2023, 13:33 by User Not Found

On September 29, the Drug Enforcement Agency (DEA) and Health and Human Services (HHS) jointly announced a secondary temporary extension allowing telehealth flexibilities for the prescription of controlled substances.

  • The full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will remain in place through December 31, 2024.
  • Additionally, this extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the first temporary rule is effectively subsumed by this second temporary rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.

The secondary temporary extension now aligns with the broader telehealth flexibilities established under the Consolidated Appropriations Act (CAA), 2023 that are set to expire on December 31, 2024. For more information, please visit the Academy’s webpage End to Public Health Emergency Waivers or contact healthpolicy@aapmr.org with any questions.

 

DEA and HHS Releases Second Temporary Extension for COVID-19 Telehealth Flexibilities

Oct 18, 2023, 13:33 by User Not Found

On September 29, the Drug Enforcement Agency (DEA) and Health and Human Services (HHS) jointly announced a secondary temporary extension allowing telehealth flexibilities for the prescription of controlled substances.

  • The full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will remain in place through December 31, 2024.
  • Additionally, this extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the first temporary rule is effectively subsumed by this second temporary rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.

The secondary temporary extension now aligns with the broader telehealth flexibilities established under the Consolidated Appropriations Act (CAA), 2023 that are set to expire on December 31, 2024. For more information, please visit the Academy’s webpage End to Public Health Emergency Waivers or contact healthpolicy@aapmr.org with any questions.

 

Explore AAPM&R

Online Learning Portal

Education is a fundamental offering that affects PM&R physicians across clinical focuses, practice areas, career stages and levels of expertise. As part of Academy membership, we provide top-notch education and other innovative learning resources across a variety of delivery mechanisms.

Access AAPM&R’s popular Online Learning Portal, which features educational resources, including case studies, instructional videos and more on a variety of clinical and practice topics.



Online Learning Portal

home-page_subscription_logo

Online Education Subscription

24/7 access to our online educational resources through the end of your annual membership cycle. Check out what's included below!

step-lockup

STEP Certificate Programs

AAPM&R’s highly-regarded STEP Certificate Programs are designed by physiatrists for physiatrists and teach and assess important physiatric skills using a progressive, competency- based curriculum.

phyzforum-omc-fnl

PhyzForum

PhyzForum is an online physiatry community that allows you to engage with peers, ask advice, and share experiences. Participate in discussions to network, collaborate, and exchange best practices with your peers.

Annual Assembly
November 12-15

12310A-1936

The 2020 Annual Assembly is virtual! Join us from November 12-15 as we meet online to share best practices and support each other as we navigate a “new normal."

Critical Conversation Series

Thursday, October 1 at 6 pm (CT)

You're invited to participate in a series of discussions on racial equity, access and inclusion in today’s world. Join us for our next conversation on October 1 for AAPM&R's Diversity and Inclusion Journey. We will review efforts that led to the creation of the D&I strategic plan, unveil our new Principles of Inclusion and Engagement and share new initiatives on the horizon.

AAPM&R News

DEA and HHS Releases Second Temporary Extension for COVID-19 Telehealth Flexibilities

Oct 18, 2023

On September 29, the Drug Enforcement Agency (DEA) and Health and Human Services (HHS) jointly announced a secondary temporary extension allowing telehealth flexibilities for the prescription of controlled substances.

  • The full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will remain in place through December 31, 2024.
  • Additionally, this extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the first temporary rule is effectively subsumed by this second temporary rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.

The secondary temporary extension now aligns with the broader telehealth flexibilities established under the Consolidated Appropriations Act (CAA), 2023 that are set to expire on December 31, 2024. For more information, please visit the Academy’s webpage End to Public Health Emergency Waivers or contact healthpolicy@aapmr.org with any questions.

 

Physiatry News

DEA and HHS Releases Second Temporary Extension for COVID-19 Telehealth Flexibilities

Oct 18, 2023

On September 29, the Drug Enforcement Agency (DEA) and Health and Human Services (HHS) jointly announced a secondary temporary extension allowing telehealth flexibilities for the prescription of controlled substances.

  • The full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will remain in place through December 31, 2024.
  • Additionally, this extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the first temporary rule is effectively subsumed by this second temporary rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.

The secondary temporary extension now aligns with the broader telehealth flexibilities established under the Consolidated Appropriations Act (CAA), 2023 that are set to expire on December 31, 2024. For more information, please visit the Academy’s webpage End to Public Health Emergency Waivers or contact healthpolicy@aapmr.org with any questions.

 

Take the Next STEP in Your Ultrasound Education

step

AAPM&R's STEP Ultrasound Certificate Program is the premiere ultrasound training program—designed by physiatrists, for physiatrists. 

As the only formal, standardized training pathway available for honing and validating your ultrasound skill set, successful completion of the STEP Ultrasound Program will clearly demonstrate to your patients, fellow health care professionals, employers, and the medical facilities you work with that you are a competent professional, expertly trained in ultrasound. 

PhyzForum AAPM&R's Online Member Community